Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Xtant Medical Holdings, Inc.

Get SEC filing alerts via email and in your feed for Xtant Medical Holdings, Inc.

XTNT

Xtant Medical Holdings, Inc.

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. develops and markets orthobiologics and spinal implant systems for treating spinal disorders. Its products include biologics, fixation, and motion preservation devices used by spine surgeons worldwide. The company leverages extensive distribution channels, strategic acquisitions, and innovative biologics to enhance patient outcomes. Focused on quality and regulatory compliance, Xtant serves the orthopedic and neurosurgical markets with a competitive edge in minimally invasive and complex spine procedures.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Xtant Medical Holdings, Inc.

1
1
Xtant Medical Holdings, Inc. Xtant Medical Reports 37% Revenue Decline in Q1 2026

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
Xtant Medical Holdings, Inc. Xtant Medical Reports 14% Revenue Growth to $133.9 Million for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Xtant Medical Holdings, Inc. Xtant Medical Reports 19% Revenue Growth to $33.3 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Xtant Medical Holdings, Inc. Xtant Medical Reports 18% Revenue Growth to $35.4 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Xtant Medical Holdings, Inc. Xtant Medical Reports 18% Revenue Growth to $32.9 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Xtant Medical Holdings, Inc. Xtant Medical Holdings Reports 28% Revenue Growth to $117.3 Million for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Xtant Medical Holdings, Inc. Xtant Medical Holdings Reports 12% Revenue Growth, Widening Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments